Pvg Asset Management »

Checkpoint Therapeutics shares owned by Pvg Asset Management

Quarter-by-quarter ownership of Checkpoint Therapeutics (CKPT) shares owned by Pvg Asset Management from 13F filings

Historical chart of Pvg Asset Management investment in Checkpoint Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Checkpoint Therapeutics held by Pvg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Checkpoint Therapeutics by Pvg Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $264k 115k 2.29
2023-09-30 $189k 111k 1.70
2023-06-30 $151k 61k 2.47
2023-03-31 $309k 137k 2.25
2022-12-31 $281k 55k 5.11

More positions owned by Pvg Asset Management

SPDR Barclays Capital 1-3 month Etf (BIL)
S&p 500 Indx Etf (IVV)
ProShares UltraShort S&P 500 Etf (SDS)
Vanguard Index S&P 500 Etf (VOO)
SPDR Portfolio S&P 500 ETF Etf (SPLG)
Invesco QQQ TR ETF SERIES 1 Etf (QQQ)
Johnson & Johnson (JNJ)
Short QQQ ProShares Etf (PSQ)
SPDR SSgA Ultra Short Bond ETF Etf (ULST)
Fortress Biotech (FBIO)
Walgreen Boots Alliance (WBA)
At&t (T)
iShares Robotics and AI Multisector Etf (IRBO)
Raytheon Technologies Corp (RTX)
Vaneck Vectors Semiconductor ETF Etf (SMH)

View all positions for Pvg Asset Management

Top funds holding Checkpoint Therapeutics

Vanguard Group
National Asset Management
Advisor Group Holdings
D. E. Shaw & Co
Pvg Asset Management
Citadel Advisors
Legacy Wealth Asset Management
Royal Bank of Canada
Park Avenue Securities
Wealth Enhancement Advisory Services
Jane Street
Lindbrook Capital
Rsm Us Wealth Management
Wells Fargo & Company
Emfo

View all funds holding Checkpoint Therapeutics